Agenda (November 16, 2009, Bethesda)
Council of Councils Meeting
November 16, 2009
National Institutes of Health (NIH)
Building 31C, Room 6
Bethesda, MD 20892
|November 16, 2009|
|9:00 a.m.||Call to Order and Introductions
Lana R. Skirboll, Ph.D., Acting Director, Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of the Director (OD), NIH
|9:10 a.m.||Announcements and Future Meeting Dates
Ms. Robin I. Kawazoe, Executive Secretary, Council of Councils
Deputy Director, DPCPSI, OD, NIH
|9:15 a.m.||Remarks from Director, NIH; the Role of the Council of Councils / and Discussion
Francis S. Collins, M.D., Ph.D.
|10:30 a.m.||Update on American Recovery and Reinvestment Act (ARRA) Funding and the Common Fund ARRA Projects / and Discussion
Lawrence A. Tabak, D.D.S., Ph.D.
Director, National Institute of Dental and Craniofacial Research, NIH
Dr. Elizabeth L. Wilder, Ph.D.
Deputy Director, Office of Strategic Coordination, DPCPSI, OD, NIH
|12:45 p.m.||Results of Survey of “Roadmap Transformative R01 Program” (T-R01) Applicants and Reviewers / and Discussion
Antonio Scarpa, M.D., Ph.D.
Director, Center for Scientific Review, NIH
|1:45 p.m.||Scientific Presentation – Molecular Libraries Roadmap / and Discussion
Christopher P. Austin, M.D.
Director, NIH Chemical Genomics Center
Senior Advisor to the Director for Translational Research, Office of the Director
National Human Genome Research Institute (NHGRI)
Associate Investigator, Genome Technology Branch, NHGRI
|3:15 p.m.||Portfolio Analysis - An Experimental Space / and Discussion
Dinah Singer, Ph.D.
Former Acting Head, Portfolio Analysis, DPCPSI
Director, Division of Cancer Biology, and
Head, Molecular Regulation Section, Experimental Immunology Branch, NCI
|4:15 p.m.||Closing Remarks
This page last reviewed on March 22, 2017